Avenue Therapeutics (ATXI) Reaches Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Avenue Therapeutics (ATXI) will participate in a Type C meeting with the FDA on March 9 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Avenue Therapeutics (ATXI) Enters into License Agreement with AnnJi Pharmaceutical to Develop and Commercialize AJ201 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Avenue Therapeutics Announces Closing of $12 Million Underwritten Public Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.